Stereotaxis Statistics
NYSE: STXSHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
1.13-0.005 (-0.44%)
Market open · Delayed 15 min · as of Oct 8, 1:48 PM ET
Stereotaxis by the numbers
Stereotaxis has a market capitalization of $112.7 million based on 100.20M shares outstanding. With trailing EPS of $-0.24, Stereotaxis is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.2% below its 50-day average and 38.6% below its 200-day average.
Average daily trading volume is 809.88K shares, or about $911,113 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
STXS valuation vs. peer median
| Metric | STXS | Peer median | Difference |
|---|---|---|---|
| Market cap | $112.73M | $86.44M | +30% |
| Avg. volume | 809.88K | 133.20K | +508% |
Peer median across 8 companies: VANI, HYPR, ECOR, NRXS, HSDT, OM, POCI, QTI.
Valuation
- Market cap
- $112.73M
- EPS (TTM)
- $-0.24
- Shares outstanding
- 100.20M
Price and trading
- Previous close
- 1.13
- Open
- 1.12
- Day range
- 1.09 – 1.13
- 52-week range
- 1.09 – 3.59
- 52-week change
- -64.47%
- Beta
- —
- Volume
- 285.15K
- Average volume
- 809.88K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2026
Additional statistics
- Market Cap
- 112.73M
- Forward Pe
- -7.26
- Eps
- -0.24
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.59
- Week52 Low
- 1.09
- Avg Volume
- 809.88K
- Shares Outstanding
- 100.20M
- Ma50
- 1.34
- Ma200
- 1.83
- Earnings Date
- Aug 11, 2026
- Pct From52w High
- -68.66%
- Pct From52w Low
- 3.21%